A pharmacy in Wisconsin has received a prescription for a ox…

A pharmacy in Wisconsin has received a prescription for a oxycodone-acetaminophen but does not have enough in stock to dispense the full quantity.  The patient would like a partial amount now and is willing to come back later to pick up the rest. Which of the following statements in TRUE?

A pharmacy licensed in Wisconsin is repackaging 500-count bo…

A pharmacy licensed in Wisconsin is repackaging 500-count bottles of metformin into 60-count bottles. The pharmacy then sells the repackaged bottles to local health care professionals who dispense them to their patients from their clinics. A licensed pharmacist supervises the repackaging. Has this product been repackaged in compliance with FDA guidance?

You find the following entries for drug products in the Oran…

You find the following entries for drug products in the Orange Book: tacrolimus capsule oral Eq 0.5 mg base AB Sandoz tacrolimus capsule oral Eq 0.5 mg base BX Accord Healthcare tacrolimus capsule, extended release oral Eq 0.5 mg base AB Astellas Pharma tacrolimus capsule, extended release oral Eq 0.5 mg base AB Chengdu Suncadia Medicine Which of the following statements is TRUE?

A pharmacy compounds a drug that matches a commercially avai…

A pharmacy compounds a drug that matches a commercially available drug’s active pharmaceutical ingredient and strength and is administered by the same route.  The only difference between the two drugs is that the commercially available drug includes a dye that makes the patient itchy, and the compounded drug does not include this dye. A patient has received a prescription for the compounded product for many years, so the pharmacy regularly compounds it in advance and dispenses it when the patient brings in their prescription. The prescription states that the compounded version provides a medical benefit for this patient. Based on the information above, is this compounded drug compliant with FDCA 503A?